openPR Logo
Press release

Global Biotechnology Market Research Reports, Competitive Analytics, Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc.

05-17-2017 09:00 AM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Global Biotechnology Market Research Reports, Competitive

The published titles of Biotechnology Market reports by iHealthcareAnalyst, Inc. include Aptamers, Array Instruments, Bioinformatics, Biopreservation, Biosensors, Cancer Genome Sequencing, Cell Culture, Cell Culture Media, Sera, Reagents, Cell Culture Protein Surface Coatings, Cell Separation Technologies, Cell Surface Markers, Computational Biology, E. coli Diagnostics Testing, Genome Engineering or Genome Editing, Human Insulin, Immunoassay Analyzers, Immunoprotein Diagnostic Testing, In Vitro Colorectal Cancer Testing, In Vitro Diagnostics, Life Science Reagents, Medical Cameras, Medical Microscopes, Meningococcal Vaccines, Metabolomics, Microbiology Cultures, Molecular Cytogenetics, Molecular Diagnostics, Monoclonal Antibody Therapeutics, Multiplexed Diagnostics, Next-Generation Sequencing, Non-alcoholic Steatohepatitis Biomarkers, Orthobiologics, Platelet Rich Plasma, Polymerase Chain Reaction, Prenatal and Newborn Genetic Testing, Protein Engineering, Regenerative Medicines, Separation Systems for Commercial Biotechnology, Single Cell Analysis, Single Nucleotide Polymorphism Genotyping, Sperm Bank, Stem Cells, Tissue Engineered Skin Substitutes, Transcriptomics Technologies, and Transfection Technologies.

The global biotechnology market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global market research reports are divided by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global reports also provide detailed market landscape (market drivers, restraints, opportunities), market attractiveness and profitability analysis as well as profiles of major competitors in the global market which includes company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Browse Global Biotechnology Reports, Competitive Analytics, Growth Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. at https://www.ihealthcareanalyst.com/reports/biotechnology/

Table of Contents
1. Introduction
2. Executive Summary
2.1. Market Size Estimation (Revenue USD Million, 2014-2021)
2.2. Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
3. Research Methodology
4. Market Landscape
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Barriers
4.1.3. Opportunities
4.2. Market Share Analysis
4.2.1. Companies
4.2.2. Products
4.3. Market Trends Analysis
4.3.1. Key success factors
4.3.2. Market Growth Rate
4.4. Market Attractiveness Analysis
4.5. Market Profitability Analysis
4.5.1. Buyer power
4.5.2. Supplier power
4.5.3. Barriers to entry
4.5.4. Threat of substitute products
4.5.5. Rivalry among firms in the industry
4.6. Distribution Channels
5. Market Segmentation
5.1. Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
5.2. Source Type
5.3. Reagents and Consumables Type
5.4. Diagnostic Test
5.5. Indication Type
5.6. Technology
5.7. Diagnostics, Therapeutic or Surgical Application
5.8. End User Groups
6. Geography (Region, Country)
6.1. North America (U.S., Canada)
6.2. Latin America (Brazil, Mexico, Rest of LA)
6.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
6.4. Asia Pacific (Japan, China, India, Rest of APAC)
6.5. Rest of the World
7. Company Profiles
7.1. Company Overview
7.2. Financial Snapshot (FY 2014-2016)
7.3. Product Portfolio
7.4. Business Strategies
7.5. Recent Developments
8. Recommendations
9. References

To request Table of Contents and Sample Pages of these reports visit:
https://www.ihealthcareanalyst.com/reports/biotechnology/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biotechnology Market Research Reports, Competitive Analytics, Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. here

News-ID: 539363 • Views:

More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/ Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5.5 Billion by 2025
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and Services Market to US$ 73.2 Billion by 2023
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by

All 5 Releases


More Releases for Ana

HISTORIC SANTA ANA LANDMARK REVITALIZED THROUGH ADAPTIVE REUSE ORDINANCE
Alliant Strategic delivers a solution by providing one of the first adaptive reuse apartment projects to fulfill a critical need for the local Santa Ana community. The newly renovated development, 888 on Main, will add 148 apartments to Downtown’s historic core, one of the most densely populated residential markets in the nation that suffers from an extreme housing shortage. With the building shell, core, mechanical systems, and underground parking already
Antechamber Solo show Ana Mazzei
Ana Mazzei Antechamber 12 November 2018– 5 January 2019 In her first solo exhibition at Green Art Gallery, Ana Mazzei fully embraces the notion of theatricality and spectatorship, both very central to her practice, to present a group of new works specifically created for the space. Titled Antechamber, the show is staged as an intermediary space between the real world outside the gallery and an imaginary ‘other space’. Walking along this in-between space, viewers have to negotiate
Intravenous Solutions Market 2018-2025 Growth Factors Ana
This report studies the global Intravenous Solutions market, analyzes and researches the Intravenous Solutions development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Baxter Hospira B. Braun Melsungen Fresenius Kabi Claris Lifesciences Grifols Vifor Pharma JW Life Science Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Browse the full report
direct/ All Nippon Airways: ANA Interim results amendment
In line 5 of paragraph 1, Operating Profit is reported as having fallen to 696.1 billion yen. This is in fact the figure for Operating Costs. The correct figure for Operating Profit is 67.0 billion yen. Please accept our apologies for this mistake. The first chart on the first page, entitled Consolidated Financial Performance, gives the correct figures. The announcement distributed by Hugin directnews. The issuer is solely responsible for the
direct/ All Nippon Airways: ANA Interim FY07 Profitable
ANA Reports Profitable First Six Months to Fiscal Year 2007 - record revenue on strong international growth TOKYO October 31, 2007 ANA Group today reported a record consolidated net profit of 105.5 billion yen on record revenue of 763.2 billion yen for first six months of fiscal year 2007, ended September 30, a 217% and 1.4% increase respectively. Net profit was boosted considerably by the sale of ANA Group´s hotel assets on
direct/ All Nippon Airways: ANA Corporate Plan FY2007
Japan´s first all business Class Jet to Link Tokyo and Mumbai - TOKYO January 25, 2007 ANA today announced its corporate plan for the 2007 fiscal year, April 1, 2007 - March 31, 2008. Fiscal 2007 constitutes the second year of ANA´s Medium-Term Strategy FY2006-2009, the aim of which is to establish ANA as Asia´s No 1 airline for quality, customer satisfaction and value creation in line with the future